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Precursors of Functional MHC Class I- or Class II-
Restricted CD8 T Cells Are Positively
Selected in the Thymus by Agonist Self-Peptides
them develop in the absence of expression of a func-
tional transporter associated with antigen processing
(TAP) as well (Sydora et al., 1996). In addition to the
expression of the atypical CD8 homodimeric isoform,
a number of other phenotypic characteristics distinguish
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peptide or the antigen for the transgenic TCR. On the
other hand, it was shown that MHC class I-restricted
TCR transgenic CD8 T cells do not develop in theSummary
absence of cognate class I MHC molecules (Cruz et al.,
1998), suggesting that they require a process of MHC-The origin and specificity of  TCR T cells that ex-
dependent selection, unlike  T cells or aberrant DNpress CD8 have been controversial issues. Here we
TCR  T cells that are present in some TCR transgenicprovide direct evidence that precursors of functional
mice.CD8 T cells are positively selected in the thymus in
Because the TCR transgenic CD8 IEL are gener-the presence of agonist self-peptides. Like conven-
ated under conditions that delete conventional T lym-tional positive selection, this agonist selection process
phocytes, their apparent escape from thymic negativerequires functional TCR-CPM, whereas it is indepen-
selection appears to be incompatible with the processdent of CD8 expression. Furthermore, CD8 ex-
of central tolerance induction. Therefore, the generationpression on mature, agonist-selected T cells does not
of transgenic TCR  CD8 IEL under conditions ofimply selection by MHC class I, and CD8 T cells
negative selection in the thymus has also been consid-can be either class I or class II restricted. Our data
ered as supportive evidence for an extrathymic pathwaydefine a distinct agonist-dependent, positive selection
(Rocha et al., 1992; Guehler et al., 1996; Cruz et al., 1998;process in the thymus, and they suggest a function for
Levelt et al., 1999). Despite this correlative evidence,CD8 distinct from the conventional TCR coreceptor
experiments designed to demonstrate the generation offunction of CD8 or CD4.
extrathymic T cells did not show a preferential accumu-
lation of CD8-expressing TCR  T cells (Rocha etIntroduction
al., 1994; Suzuki et al., 2000; Oida et al., 2000). So far,
no data exist to support extrathymic selection eventsTCR  CD8 T cells are an enigmatic and diverse
that lead to the generation of functional, antigen-specificT cell population (Rocha et al., 1991, 1994; Guy-Grand
TCR  CD8 T cells. Furthermore, the results from
et al., 1991a). In mice, they are present at multiple sites,
neonatal thymectomy and other studies have suggested
but they are most abundant and quite numerous among
a thymic origin for some precursors of CD8-express-
the intestinal intraepithelial lymphocytes (IEL) (Rocha et ing TCR  and TCR  T cells (Lin et al., 1993; Lefran-
al., 1994). The specificity of the TCR  CD8 T cells cois and Olson, 1994). Similar conclusions were drawn
remains unknown, although in normal mice large num- from a recent study using TCR  transgenic systems
bers of superantigen-reactive TCR T cells accumu- (Guy-Grand et al., 2001). Nevertheless, this study did
late among CD8-expressing lymphocytes (Rocha et not provide evidence that indicates that TCR  thymic
al., 1991). While all TCR  CD8 IEL require 2m precursors undergo a positive selection process in the
expression, they are not exclusively restricted by the thymus that leads to mature and functional CD8 TCR
classical class I molecules K and D (Gapin et al., 1999;  T cells in the periphery.
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also provides direct evidence that a selection process CD8 Expression Does Not Correlate with MHC
Class I TCR Specificityof the precursors of these agonist-dependent CD8
In mice without a TCR transgene, CD8 T cells thatT cells is occurring in the thymus. Second, the require-
express V segments reactive with endogenous super-ment for a functional -CPM indicates that the selection
antigens presented by MHC class II are present amongevent is a true positive selection process, rather than
IEL (Rocha et al., 1991; Poussier et al., 1992), whilean escape of these thymic precursors from agonist-
conventional T cells with this specificity are deletedinduced negative selection. Third, we provide evidence
(Kappler et al., 1988; MacDonald et al., 1988).that selection of CD8 thymocytes by agonist self-
Class II-restricted TCR transgenic mice were analyzedpeptide occurs regardless of the MHC restriction of their
to investigate if the correlation of CD8 expressionTCRs. This indicates that, although mature CD8
with agonist signals also pertains to peptide-specific,T cells require 2m-dependent MHC class I expression,
class II-restricted TCRs. The AND TCR and the 5C.C7CD8 is not acting as a coreceptor by interacting with
TCR are both specific for a pigeon or moth cytochromethe same MHC molecule recognized by the TCR ex-
c (MCC) peptide presented by the I-Ek MHC class IIpressed on those T cells. This further underscores the
molecule, and they contain identical rearranged V3fact that CD8must play a role distinct from the classi-
TCRs coexpressed with closely related V11 polypep-cal TCR coreceptors, CD8 and CD4.
tides (Hedrick et al., 1982; Fink et al., 1986). Both TCRs
are positively selected by I-Ek (Figure 1B). The AND TCR
can also be positively selected by I-Ab (Kaye et al., 1992;Results
Matechak et al., 1996; Yelon and Berg, 1997) and (Figure
1B). Futhermore, the AND TCR has a higher affinity than
CD8 Expression Correlates with Expression
the 5C.C7 TCR for self-peptides presented by I-Ek, and
of Agonist Self-Peptides it was proposed (Matechak et al., 1996; Yelon and Berg,
In MHC class I-restricted TCR transgenic systems, in- 1997) that this higher affinity induces partial negative
cluding the H-Y/Db-specific B6.2.16 TCR, TCR  selection. This was manifested in the thymus by a 5-fold
CD8 transgenic T cells accumulated in the presence reduction of total thymocyte number (1.6  107 on aver-
of the cognate antigen (Figure 1A), while conventional age, n  10) in the AND TCR/I-Ek animals as compared
T cells were deleted. The H-Y TCR system historically to the AND TCR/I-Ab or 5C.C7 animals, a reduced per-
has been a paradigm for defining TCR selection. It may centage of DP thymocytes (Figure 1B), and an increased
be atypical, however, as evidenced by the accumulation proportion of DN cells (Figure 1B). In agreement with
of large numbers of peripheral TCRlow T cells in H-Y previous results, however, positive selection of mature
antigen positive male mice and few mature T cells in CD4 thymocytes occurred in all three strains of mice
positively selecting female H-Y TCR transgenic mice (Figure 1B, upper panels). IEL from both the AND TCR/
(Bruno et al., 1996; Cruz et al., 1998). We therefore con- I-Ek (4.7  105  2.8  105, n  10) and the 5C.C7 (5.5 
firmed the correlation of agonist self-peptide expression 105 3.3 105, n 5) mice were comparable in absolute
with CD8 TCR  transgenic T cells, using mice number. Surprisingly, however, IEL from the two strains
transgenic for the class I-restricted V2V5 OT-1 had a very different phenotype, with predominantly
CD8 IEL in the AND TCR/ I-Ek mice and exclusivelyTCR, which is specific for a chicken ovalbumin (OVA)
CD4 IEL in the 5C.C7 mice (Figure 1B, lower panels).peptide presented by H-2Kb (Kurts et al., 1996). Positive
The phenotype of the AND TCR/I-Ab IEL was similar toselection of this TCR in the thymus resulted in the gener-
the 5C.C7 IEL although significantly fewer IEL (1.8 ation of abundant, SP CD8 thymocytes (Figure 1A).
104  0.7  104, n  5) were present in this strain (Fig-Consequently, large numbers of CD8 transgenic
ure 1B).V2V5 T cells accumulated in the spleen (1.3 107 
Although the AND TCR/I-Ek system shows partial neg-0.5  107 ) and intestine (4.4  106  1.9  106) of OT-1
ative selection, the generation of CD8class II-restrictedTCR transgenic mice (n  6). The introduction of the
T cells was also investigated under conditions of com-OVA antigen, by crossing these mice to mice expressing
plete negative selection. The previously described (Di-membrane-bound OVA antigen transgene under the
Giusto and Palmer, 1994) 3BBM74 TCR, encoded bycontrol of the rat insulin promoter (RIP-mOVA mice)
V2.1/V8.1 genes, is alloreactive for the MHC class II(Kurts et al., 1996), resulted in negative selection of TCR
molecule, I-Abm12. It is positively selected in mice ex-transgenic CD8 single-positive thymocytes (Figure 1A).
pressing I-Ab but negatively selected in mice on the
This was also evidenced by a nearly 10-fold decrease
I-Abm12 background (Backstrom et al., 1998). As reported
in the absolute number of TCR transgenic CD8 previously, the negatively selecting condition results in
splenocytes (1.5  106  0.6  106, n  4). By sharp the clonal deletion of all CD4 thymocytes (Figure 1B,
contrast, the absolute number (5.1  106  1.2  106) upper panel) and CD4 peripheral T cells, including all
of V2V5 IEL did not decrease in the presence of CD4 IEL (Backstrom et al., 1998; Capone et al., 2001;
the OVA antigen transgene. Furthermore, similar to the data not shown).
IEL of male H-Y TCR transgenic mice (Figure 1A), a In contrast, but consistent with the other TCR sys-
significant population of CD8 TCR  transgenic tems, T cells expressing CD8 accumulated among
T cells accumulated when the OVA antigen was coex- the IEL (Figure 1B, lower panel) and other peripheral
pressed (Figure 1A). These data are also consistent with tissues, including the spleen (Figure 4), bone marrow,
the results from the 2C (Guehler et al., 1996) and F5 and liver (data not shown) of the I-Abm12 3BBM74 TCR
transgenic mice. Furthermore, the percentage of 3BBM74(Levelt et al., 1999) class I-restricted TCR systems.
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Figure 1. CD8-Expressing IEL Correlate with the Presence of Agonist Self-Peptide, Regardless of TCR Specificity
(A) Analysis of thymocytes and IEL of mice transgenic for class I-restricted TCRs. OT-1 TCR transgenic mice and H-Y TCR RAG2	/	 transgenic
female mice are categorized as relatively low-affinity TCR systems in terms of the self-peptides present, and antigen-bearing RIP-mOVA
(OVA) OT-1 TCR transgenic mice and H-Y TCR RAG2	/	 transgenic male mice are categorized as high-affinity TCR systems. The numbers
indicate the percentage of TCR  transgenic CD8 single-positive thymocytes (top row) and TCR transgenic CD8 IEL (bottom
row).
(B) Analysis of thymocytes and IEL of mice transgenic for class II-restricted TCRs. AND TCR/I-Ab RAG2	/	 transgenic mice and 5C.C7 TCR/
I-Ek RAG2	/	 transgenic mice were classified as low-affinity TCR systems, and the AND TCR/I-Ek RAG2	/	and antigen-bearing I-Abm12 3BBM74
TCR transgenic RAG2	/	 mice were classified as high-affinity TCR systems. The numbers indicate the percentage of TCR  transgenic CD4
single-positive thymocytes (top row) and TCR  transgenic CD8 IEL (bottom row). The data are representative of at least two experiments
in every case.
TCR expressing IEL in the transgenic mice on the I-Abm12 of an agonistic TCR signal, regardless of the MHC re-
striction of that TCR.background was increased on average 8- to 10-fold
(22.3%, n  3) as compared to the I-Ab control mice
(2.5%, n 
 4), making the agonist-dependent increase The Thymus Is Critical for Efficient Generation of
CD8-Expressing Class I-Restricted TCR  T Cellsin the number of CD8-expressing IEL even more ap-
preciable. To directly investigate the role of the thymus in the
generation of CD8-expressing TCR  T cells, weIn summary, the data for different MHC class I- and
class II-restricted TCRs consistently demonstrate a cor- carried out grafts of thymus tissue from TCR transgenic
donor mice into immune-deficient recipient mice. Adultrelation between CD8 expression and the presence
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Figure 2. The Expression of Cognate Antigen by Thymus Grafts from TCR Transgenic Donor Mice Promotes the Generation of
CD8-Expressing IEL
(A) Shown is a bar graph of the absolute numbers of CD8-expressing TCR transgenic IEL, recovered from RAG	/	-recipient mice 6 weeks
after reconstitution with thymus grafts from TCR/cognate antigen transgenic donor mice, either OT-1 TCR/RIP-mOVA (pool of four) or H-Y
TCR/H-Y (n  3). Also shown is the absolute number of CD8-expressing IEL from control RAG	/	-recipient mice that received thymus
grafts from TCR transgenic donor mice OT-1 (pool of four) or H-Y TCR (n  4) that did not express the cognate antigen. Shown are the
averages of the indicated numbers of experiments for the H-Y TCR transgenic mice.
(B) Bar graph of the absolute number of CD8-expressing H-Y TCR IEL recovered from RAG	/	-recipient mice that had received thymus
grafts from H-Y TCR transgenic donor mice that were CD8	/	. Shown are the average numbers of two experiments.
thymus was grafted, as opposed to neonatal tissue, numbers of CD8-expressing T cells in any of the recip-
ient mice, even when self-antigen was present in thebecause the intestinal TCR  T lymphocytes arise after
the second week after birth, and unlike the TCR  IEL, periphery of the recipient mice (Figure 2A). The lack of
CD8-expressing IEL when H-Y	 female thymus wasintestinal TCR  T cells gradually expand throughout
young adulthood (Kuo et al., 2001). Furthermore, nega- transplanted into male H-Y recipients suggests that
the TCR  CD8 IEL generated by the H-Y thymustive selection in neonatal thymus is incomplete. The
results from grafting positively selecting thymus tissue, grafts were derived from a selection process in the thy-
mus, as opposed to H-Y antigen-driven expansion ofobtained either from the OT-1 TCR or female H-Y TCR
transgenic donor mice, were compared to thymus grafts recirculating mature T cells. To confirm this, splenic
tissue from the same H-Y TCR transgenic donor animalsfrom donor mice expressing agonist self-peptide as well,
including the OT-1 TCR/RIP-mOVA transgenic mice and was also grafted. Although these spleen grafts reconsti-
tuted splenic and lymph node T cell populations, as wellmale H-Y TCR transgenic mice. The two systems differ
with regard to agonist peptide expression in the periph- as CD8-expressing IEL, none of the spleen grafts
generated CD8-expressing TCR transgenic IEL, re-eral tissue of the recipient mice. In the OT-1 system,
the recipient mice are OVA negative, whereas male or gardless of the expression of cognate antigen by the
spleen grafts themselves or the recipient mice (data notfemale H-Y TCR transgenic thymus tissue was grafted
into either H-Y antigen-expressing male or H-Y antigen- shown).
In summary, these data verify that TCR  CD8negative female RAG	/	 recipient mice. This allowed us
to use the H-Y system to evaluate the effect of agonist IEL can originate from precursors in the thymus. Further-
more, they clearly indicate that these cells are depen-expression in the periphery in the selection of thymus-
derived precursors. dent upon expression of agonist self-peptides in the
thymus, consistent with selection of those precursorsAs expected, positively selecting thymus grafts readily
reconstituted the spleen and lymph nodes in the in the thymus. The complete absence of CD8-
expressing T cells in the recipient mice of spleen grafts,RAG	/	-recipient mice (data not shown). On the other
hand, due to negative selection, thymus grafts from do- which are highly enriched for mature T cells, rules out
the possibility that recirculating mature T cells generatenor mice expressing cognate self-antigen did not recon-
stitute these peripheral compartments efficiently (data these CD8-expressing IEL. Furthermore, the exclu-
sive ability of agonist-expressing thymus grafts to gen-not shown). By contrast, an opposite pattern was ob-
served when IEL were analyzed. Antigen-expressing erate these CD8-expressing T cells argues against
homeostatic expansion of these cells in RAG	/	 recipi-thymus grafts from the OT-1 TCR/RIP-mOVA transgenic
donor mice generated a significant population of ent mice as the sole mechanism driving the reconsti-
tution.CD8 TCR  IEL, although the only source of OVA
antigen in these recipient mice was the thymus graft
itself (Figure 2A). Similarly, grafting of thymus tissue TCR  CD8 T Cells Do Not Require
CD8 Expressionfrom H-Y TCR transgenic H-Y male donor mice into
either male (H-Y) (Figure 2A) or female (H-Y	) recipient Expression of CD8 on immature thymocytes is re-
quired for positive selection of conventional classmice (data not shown) also gave rise to transgenic TCR
 CD8 IEL. Self-antigen negative thymus grafts, I-restricted CD8 T cells in normal mice and H-Y TCR
transgenic mice (Crooks and Littman, 1994). It is noteither from the female H-Y TCR transgenic or OT-1 TCR
transgenic donor mice, did not generate any significant known at what stage the induction of the CD8 expres-
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sion occurs on TCR  T cells or if they require CD8 Generation of CD8-Expressing T Cells Requires
the  Chain-Connecting Peptide Domainexpression on their precursor thymocytes. It is possible
that they initially require signals mediated by CD8 in The observation that CD8-expressing T cells prefer-
entially develop in the presence of agonist self-peptideconjunction with the TCR and that turning off CD8
expression is part of a strategy to avoid negative selec- suggests an avidity-dependent selection process for
these T lymphocytes whereby the driving force generat-tion (Barnden et al., 1997).
To investigate this, H-Y TCR transgenic RAG 2	/	mice ing these cells is negative selection and a process
allowing their escape from cell death. It has been shownwere crossed onto the CD8	/	 background. As a con-
sequence, positive selection in female CD8	/	H-Y TCR recently, using the above described 3BBM74 TCR trans-
genic system, that the TCR  chain-connecting peptidetransgenic mice, as well as conventional negative se-
lection in male CD8	/	 H-Y TCR transgenic mice, is domain motif (-CPM) is involved in activating the posi-
tive selection pathway through its specific recruitmentdefective (Crooks and Littman, 1994). The absence of
conventional selection, however, did not prevent the of the extracellular signal-regulated kinase (ERK) (Back-
strom et al., 1998). 3BBM74 TCR transgenic mutant micedevelopment of TCR  transgenic CD8-expressing
T cells in the male CD8	/	 H-Y TCR transgenic mice. that expressed a TCR  chain in which this motif was
deleted failed to positively select the 3BBM74 TCR inThe number of CD8-expressing H-Y TCR IEL in male
CD8	/	 mice (2–4  106, n  4) was comparable with the presence of I-Ab. Conventional negative selection
on the deleting I-Abm12 background was unaffected inthe number of H-Y TCR IEL (2–4  106, n 
 10) in their
CD8 counterparts. Similarly, in CD8	/	 mice that did these -CPM mutant mice (Backstrom et al., 1998).
3BMM74 TCR transgenic mice with a knockin of thenot express a TCR transgene, the number of TCR 
CD8 IEL was not greatly affected by CD8 deficiency -CPM mutation in their TCR  chain and crossed onto
the I-Abm12 negatively selecting background were there-(data not shown). Because CD8 is required for the
positive selection of most conventional CD8 T cells, fore analyzed for the presence of CD8-expressing
T cells. Numerous CD8-expressing cells can be re-the data suggest that there are distinct selection require-
ments for agonist-selected TCR  lymphocytes. trieved from the intestine (Figure 1B) and peripheral tis-
sues, including the spleen (Figure 4), of control 3BMM74Thymus transplants from CD8	/	 H-Y TCR trans-
genic donor mice were carried out to investigate directly TCR transgenic mice with a wild-type C chain and the
alloantigen I-Abm12. By contrast, no CD8-expressingthe role of the thymus in this process. The data also
indicate that antigen-expressing thymus grafts from 3BBM74 TCR T cells could be isolated when the -CPM
was mutated (Figure 4 and data not shown). This wasCD8	/	 male (H-Y) donor mice were consistently most
efficient in reconstituting the IEL in the recipient mice in sharp contrast to the aberrant TCRlow CD8 T cells,
which, in agreement with previous results (Backstrom(Figure 2B), similar to their counterparts from CD8
donors. et al., 1998), accumulated in peripheral tissues regard-
less of the mutation in the -CPM (Figure 4). Therefore,These results indicate that the agonist-dependent al-
ternative selection pathway in the thymus does not re- aberrant T cells that express low levels of TCR probably
do not undergo positive selection. These aberrant T cellsquire CD8 expression.
are not found to a significant extent among IEL, and
therefore few IEL can be obtained from 3BMM74 TCRMHC Class II-Restricted CD8-Expressing
transgenic/I-Abm12 mice with a mutated -CPM.T Cells Are Thymus Dependent
In summary, the data indicate a critical role for theUsing a second approach, we investigated whether the
-CPM of the TCR  chain in the selection of agonist-thymus is also required for the agonist-selected MHC
dependent TCR  T lymphocytes, and they suggestclass II-restricted T cells that develop in the AND TCR/
that this alternative selection pathway involves ERK-I-Ek transgenic mice. Because immune-deficient recipi-
dependent signaling. Therefore, this agonist selectionent mice on the H-2k background were not available to
process must require signals other than, or in additionus for graft experiments, we analyzed BM cells from
to, those required for negative selection.AND TCR transgenic donor mice for their ability to recon-
stitute T cells in thymectomized or euthymic irradiated
recipient mice. Donor BM cells from TCR AND/H-2b Agonist-Dependent Class I-Specific CD8
T Cells Are FunctionalRAG	/	 mice were transferred to irradiated C57BL/6
(I-Ab) or B10.BR (I-Ek) recipient mice that were either To examine if this selection pathway can give rise to
functional lymphocytes, IEL and splenocytes from anti-euthymic or thymectomized. As expected, all euthymic
recipient mice had significant numbers of TCR trans- gen-expressing MHC class I-restricted TCR transgenic
mice (OT-1 TCR/RIPmOVA or H-Y TCR/H-Y) were incu-genic donor cells in their lymph nodes (data not shown),
spleen (Figure 3A, upper panels), and IEL (Figure 3A, bated with labeled APCs preloaded with the cognate
peptides, SIINFEKL from OVA for OT-I or KCSRNRQYLlower panels) 8 weeks after BM transfer. On the other
hand, donor AND TCR transgenic BM cells did not re- from Smcy for the H-Y TCR. Antigen-specific cytotoxic
responses were measured for IEL and compared withconstitute any of these T cell compartments in the thy-
mectomized recipient mice, including spleen (Figure 3B, splenocytes. As can be seen in Figure 5A, IEL from both
types of antigen-bearing TCR transgenic mice displayedupper panels) and IEL (Figure 3B, lower panels).
These data indicate an absolute requirement of the antigen-specific cytotoxicity. As expected, CD8TCR
transgenic splenocytes did not respond well, as thesethymus for all class II-restricted TCR transgenic T cells,
including the CD8-expressing IEL in I-Ek-recipient cells require activation before displaying cytotoxicity
(Figure 5A). To investigate directly if the thymus-mice.
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Figure 3. Six- to Eight-Week-Old C57BL/6
and B10BR Animals Were Thymectomized or
Sham Operated
Two weeks after the operation, the animals
were lethally irradiated (1200 Rads) and re-
constituted with the injection i.v. of 5–10 
106 T cell-depleted bone marrow cells from
AND RAG	/	 I-Ab donor mice. Six weeks after
reconstitution, the animals were sacrificed,
and the percentage of bone marrow-derived
transgenic T cells present in the spleen (upper
panels) and IEL (lower panels) was deter-
mined by flow cytometry using anti-V3 and
anti-V11 mAbs. Data are representative of
two to three animals analyzed for each con-
dition.
selected agonist-dependent T cells also displayed anti- peptide injection and underwent significant antigen-
driven expansion, which resulted in an up to 5-fold in-gen-specific reactivity, we tested IEL from recipient
mice that had received OVA antigen-expressing thymus crease 7 days later (Figure 6). CD4 IEL in the 5C.C7
TCR transgenic mice initially decreased 24 hr postinjec-grafts from OT-1 TCR/RIP-mOVA donor mice. The OT-1
TCR IEL that were selected in the presence of OVA tion, but they subsequently reappeared in enhanced
numbers (Figure 6). Interestingly, a significant popula-antigen also displayed an OVA-specific cytotoxic activ-
ity (Figure 5B). Similar results were obtained with thy- tion of CD8-expressing transgenic T cells appeared
among the recovering T cell population of antigen-mus-derived IEL from H-Y-expressing TCR H-Y trans-
genic male donor mice (data not shown). injected 5C.C7 TCR transgenic mice, indicating a corre-
lation between CD8 induction and T cell activation in
vivo (Figure 6).Class II-Restricted CD8-Expressing IEL
In summary, the data show that agonist-dependent,Are Functional and Respond to
class II-restricted T cells also exhibit antigen-specificClass II-Presented Peptide
responsiveness, and the CD8-expressing T cells accu-We investigated the in vivo responsiveness and specific-
mulating in the antigen-injected 5C.C7 TCR transgenicity of CD8 and CD4 IEL generated in class II-restricted
mice further suggest that conventional selected T cellsTCR transgenic/I-Ek mice. It was shown previously that
can induce CD8 upon antigenic stimulation.T lymphocytes expressing this TCR do not depend on
CD4 coreceptor expression for in vitro responses (Mor-
rissey et al., 1995). AND TCR and 5C.C7 TCR transgenic Discussion
mice on the I-Ek background were injected with the cog-
nate MCC peptide and analyzed either 24 hr or 7 days The data presented here provide direct evidence for
a distinct, agonist-dependent selection pathway in thelater. TCR transgene CD8-expressing IEL, present in
the AND/Ek transgenic mice, increased by day 1 post- thymus. This novel selection process depends upon a
Figure 4. Class II-Restricted CD8-Expressing T cells Are Selected by a Pathway That Involves -CPM
(A) Analysis of CD8 and CD8 expression of transgenic TCR-expressing thymocytes and spleen cells isolated from I-Abm12 mice expressing
the 3BBM74 TCR transgene and containing either the wild-type C (control) or the -CPM-mutated  chain of the TCR transgene (-CPM	).
(B) Level of transgenic TCR expression by -CPM-dependent CD8-expressing splenocytes and by -CPM-independent CD8-expressing
T cells. Shown is the mean fluorescence of TCR V8 staining when gated on the CD8- or CD8-expressing cells. Data are representative
of two experiments.
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Figure 5. MHC Class I-Restricted TCR Transgenic IEL Selected in the Presence of Cognate Antigen Have Antigen-Specific Cytotoxic Function
(A) Antigen-specific cytotoxicity of IEL and splenocytes of OT-1 TCR/RIP-mOVA mice or H-Y TCR/H-Y mice, using RMA-S target cells loaded
with the relevant peptides.
(B) Antigen-specific cytotoxicity of OT-1 TCR transgenic IEL isolated from RAG 2	/	-recipient mice, 6 weeks after reconstitution with thymus
graft from OT-1 TCR/RIP-mOVA transgenic donor mice. RMA-S cells loaded with the OVA peptide or the irrelevant H-Y peptide were used
as target cells. Effector:target (E:T) ratios are calculated on the actual number of TCR transgene cells in each cell preparation as determined
by flow cytometry. These are representative data from one of two experiments.
high-affinity interaction of the TCR with ligand ex- thymus. Second, they show that an agonist signal is
required for maturation of those precursors and that thispressed in the thymus, and it results in differentiation
to mature and functional T cells that express CD8. signal needs to be given in the thymus and not in the
periphery. Third, they show that this agonist selectionSelf-agonist-driven selection of T cells is consistent with
observations in normal mice where CD8 T cells are pathway, which is MHC dependent for both class I (Cruz
et al., 1998)- and class II (data not shown)-restrictedenriched for cells expressing endogenous superantigen
reactive V’s, while these V’s are deleted from the TCRs, is ERK dependent and, therefore, is a true positive
selection process, as opposed to an escape of theseconventional T cell pool (Rocha et al., 1991; Badiner et
al., 1993). precursors from agonist-induced negative selection.
Additionally, our results show that these agonist-Although our results agree with previous observations
regarding the correlation of CD8 IEL and agonist self- selected T cells are not aberrant or anergic and that
they retain function and antigen specificity in vitro andpeptide, they completely disagree with the hypotheses
that were generated from those observations. First, the in vivo. Antigen-specific function has not been demon-
strated for CD8 IEL-generated in systems that ana-novel findings here clearly show that precursors of
CD8 mature T cells undergo a selection event in the lyzed for extrathymic differentiation. This further under-
Figure 6. MHC Class II-Restricted TCR Trans-
genic Cells That Express CD8 Are Antigen
Responsive
5C.C7 RAG	/	 (I-Ek) and AND RAG	/	 (I-Ek)
mice were injected i.v. with 200 g of MCC
88-103 peptide. At the indicated time points
after injection, the animals were sacrificed,
and IEL were isolated and stained with mAbs
against V3, V11, CD4, and CD8 and ana-
lyzed by four-color flow cytometry. The total
cell number was obtained from the total cell
yield from the Percoll gradient interface
multiplied by the percentage of V3/V11
cells in the preparation. This cell number was
then multiplied by the percentage of trans-
genic T cells being CD4 or CD8. Mice 6
to 10 weeks old of both sexes were used.
Between one and ten mice were analyzed for
each time point, and the data represent the
mean cell number of each transgenic IEL pop-
ulation found in these animals with the
variation 20%.
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scores the fact that the TCR transgenic CD8- other data indicating that CD8 is not an effective TCR
expressing T cells are bona fide TCR  T cells that, coreceptor (Gao and Jackobsen, 2000), including the
unlike TCR  T cells or aberrant TCR  T cells, depend finding that, in the absence of CD8, CD8 does not
entirely on thymic positive selection driven by MHC efficiently positively select CD8 single-positive T cells.
class I or class II molecules for their development and Furthermore, it has been shown that CD8 lacks the
maturation. In mice without TCR transgenes, other T cell lipid modification that allows CD4 and CD8 to colocal-
populations exist that might undergo an agonist-driven ize with the engaged TCR in lipid rafts (Arcaro et al.,
thymic selection pathway, such as the CD4 CD25 2000), a condition that might be required for coreceptor
regulatory T cells (Jordan et al., 2001) and NK T cells function (Arcaro et al., 2000). Collectively, the data pre-
(Bendelac et al., 1997; Capone et al., 2001). sented here provide direct evidence for an agonist-
The selection process induced by agonistic signals dependent thymus selection pathway through which the
generated in the thymus raises interesting issues re- immune system preserves and selects T cells whose
garding positive and negative selection as well as self- TCR affinity precludes them from the population of con-
tolerance. The possibility must be considered that high- ventional T cells. This allows the immune system to
affinity TCR interactions can lead to both apoptosis of make efficient use of T cell receptors with relatively
DP thymocytes during conventional negative selection high affinity for self in order to provide specialized T
as well as export of alternatively selected thymocytes lymphocytes that can respond rapidly, without inducing
expressing the same high-affinity TCRs. The agonist unnecessary immune responses to nonpathogenic anti-
selection process is likely to have important implications gens and which may be able to survey for stressed
for the function of those T cells and, in particular, for cells. CD8 expression does not define exclusively this
the IEL population. This selection pathway might under- agonist-selected T cell lineage, but the induction of
lay the activated phenotype of IEL (Sydora et al., 1993) CD8 on T cells, regardless of their TCR specificity or
as well as their rapid cytokine and cytolytic responses selection process, may subject them to a regulatory
(Guy-Grand et al., 1991b) and the apparent lack of a mechanism that induces self-tolerance and allows acti-
CD28 costimulation requirement (Ohteki and MacDon- vated T cells to survive and function in highly specialized
ald, 1993). These properties for IEL could reflect the microenvironments, such as the mucosal epithelium.
adaptation of these lymphocytes to the mucosa, where
a rapid response might be highly beneficial in a microbe- Experimental Procedures
rich environment. The ability of these cells to respond
Mouse Breeding and Typingto self-antigens could reflect their competence to survey
All transgenic mice were on the RAG-deficient background with thefor enhanced expression of self as an indication of
exception of the OT-1 mice. H-Y TCR transgenic mice, a gift fromstressed cells, thus evading unnecessary immune re-
Dr. Wendy Shores at the National Institutes of Health (Bethesda,
sponse toward nonpathogenic antigens that are plentiful MD), were crossed onto the RAG-2	/	 background. H-Y TCR/RAG-
in the mucosal environment. On the other hand, this 2	/	/CD8	/	 mice were from the F2 generation of an intercross
potential for autoreactivity suggests that failure to regu- between H-Y TCR/RAG-2	/	 mice and CD8	/	 mice (a gift from
Dr. Daniel Littman, the New York University School of Medicine,late these T cells might cause chronic inflammation and
New York, NY). Anti-CD19 (clone 1D3, Pharmingen, CA) and anti-autoimmunity.
CD8 (clone 53-5.8, Pharmingen, CA) monoclonal antibodies wereRecently, we have shown that CD8 acts semiauton-
used to identify RAG and CD8 deficiency, respectively. The pres-
omously and not as a TCR coreceptor (Leishman et al., ence of the H-Y TCR transgene was detected by PCR as described
2001). CD8 interacts specifically and with high affinity previously (Cruz et al., 1998). OT-1 TCR transgenic and RIP-mOVA
with the nonclassical class I molecule TL that is ex- transgenic mice were a gift of Dr. William R. Heath (Walter and Eliza
pressed abundantly by intestinal epithelial cells. This Hall Institute of Medical Research, Melbourne, Australia). They were
crossed with each other to produce a double transgenic F1 strain.interaction is independent of the TCR specificity for pep-
Mice transgenic for both transgenes were identified by flow cytome-tide/MHC, and it significantly modifies responses medi-
try with V5 and V2 antibodies (clones MR9-4 and B20.1, respec-ated by the TCR. It is suggested that this unique interac-
tively, Pharmingen, CA) for the TCR transgene and by PCR (5 primer
tion allows CD8-expressing T cells to adapt and sequence CAAGCACATCGCAACCA, 3 primer sequence GCAATT
survive in an antigen-rich environment and to establish GCCTTGTCAGCAT) for the RIP-mOVA transgene. AND TCR trans-
self-tolerance. Interestingly, CD8 can also be induced genic mice (Kaye et al., 1992) were crossed to inbred RAG-2	/	(H-2b)
mice to obtain AND RAG	/	(H-2b). AND B10BR (H-2k) (a gift fromon activated, conventional T cells, as was suggested
Dr. Howard Gray, La Jolla Institute for Allergy and Immunology,from the results presented here. Coexpression of CD8
San Diego, CA) were backcrossed to AND RAG	/	(H-2b) mice toon activated T cells is also supported by our recent
generate AND RAG	/	 mice on an H-2k background. 5C.C7finding that the majority of CD8 IEL also expresses
RAG	/	(H-2k) TCR transgenic mice were purchased from Taconic.
CD8 (Leishman et al., 2001) and by previous observa- 3BBM74 TCR RAG-2	/	 transgenic mice and -CPM mutant
tions that CD8 is readily induced on conventional 3BBM74 TCR transgenic mice were generated and typed as de-
CD4 mature splenocytes upon antigen-driven migra- scribed previously (Backstrom et al., 1998); backcrosses of these
3BBM74 TCR transgenic mice to class II I-Ab or I-Abm12 haplotypetion of these cells to the intestine (Morrissey et al., 1995).
mice were used to introduce a positively or negatively selectingThe correlation of CD8 expression with T cell activa-
background, respectively. All mice were housed under specifiction disqualifies CD8 per se as a reliable marker to
pathogen-free conditions in the vivarium of the La Jolla Institute fordefine a specific T cell lineage; rather, it appears to
Allergy and Immunology or the Basel Institute for Immunology.
define a T cell differentiation stage. Furthermore, the
data presented here indicate that the expression of Preparation of Lymphocytes
CD8 does not necessarily imply class I restriction of Thymus and spleen were excised and single-cell suspensions were
the TCR, as CD8 can be expressed on class I- as well prepared by grinding the organs between the frosted ends of two
glass slides in RPMI 1640 medium. IEL were prepared as describedas on class II-restricted T cells. This is consistent with
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previously (Cruz et al., 1998). In brief, small intestines were removed hr prior to the assay to eliminate the excess of nonspecific NK killing
activity characteristic of cells from immune-deficient mice. Effectorand cleaned, flushed of fecal content, and opened longitudinally.
Intestines were then cut into 0.5 cm pieces, transferred into 250 ml and target cells were mixed and spun before 5 N HCl was added
to wells designed for maximal release. Plates were incubated atErlenmeyer flasks, and shaken 3 at 200 rpm for 30 min at 37C in
HBSS without Ca2or Mg2 and containing 1 mM DTT (Sigma Chemi- 37C/5% CO2 for 4 hr, and the supernatant from each well was
counted in a / scintillation counter (1450 MicroBeta Trilux, Wallac,cal Co., St. Louis, MO). The cell suspensions were passed through
a 60 m nylon mesh and pelleted by centrifugation/1200 rpm. The Gaithersburg, MD). Specific lysis was calculated as ([experimental
counts 	 spontaneous counts]/[maximum counts 	 spontaneouscell pellets were resuspended in 20% Percoll (Pharmacia, Piscata-
way, NJ), layered over a 40/70% Percoll gradient, and centrifuged counts])  100. Similar results were obtained using RMA-H, the
TAP-sufficient parent cell of RMA-S, as the target cells.at 900 g for 25 min. Cells from the interface were collected,
washed, and resuspended in complete RPMI 1640/5% FCS medium.
Acknowledgments
Flow Cytometry Analysis
We thank Marieke Cheroutre for her contribution and Chris Lena,IEL or other cell preparations were suspended in PBS (pH 7.4) con-
Ed Lemmens, and Barbara Hausmann for breeding mice. This worktaining 2% (w/v) BSA and 0.02% NaN3. After blocking with the 2.4G2
was supported by National Institutes of Health Grants DK 54451anti-FcR mAb for 15 min at 4C, cells were stained according to
(H.C.) and DK 46763 (M.K.). L.G. was supported by fellowships fromstandard procedures and analyzed on a Becton-Dickinson FACScan
l’Association pour la Recherche contre le Cancer and from the Can-(San Jose, CA) 440 flow cytometer or FACScalibur. Lymphocytes
cer Research Institute. The Basel Institute for Immunology waswere enumerated from IEL preparations by electronic gating, as
founded by F. Hoffmann-La Roche Ltd., Basel, Switzerland. This isdetermined by analysis of FSC and SSC. The following mAbs were
manuscript number 430 from the La Jolla Institute for Allergy andused for phenotypic analysis of cells: biotinylated or PE-labeled anti-
Immunology.V3 clone KJ23, PE-labeled anti-V8.1/8.2, biotinylated anti-V3 clone
T3.70, PE-conjugated anti-V5 clone MR9-4, FITC-labeled anti-V11
Received July 13, 2001; revised January 8, 2002.clone, FITC-labeled anti-V2 clone B20.1, FITC-labeled anti-CD4
clone GK1.5 or H129.19, PE- or FITC-labeled anti-CD8 clone 53-
References7.3 or 53-6.7, PE-labeled anti-CD8 clone 53.5.8, and biotinylated
or PE-conjugated anti-TCR clone H57-597. All mAbs, except T3.70
Arcaro, A., Gregoire, C., Boucheron, N., Stotz, S., Palmer, E., Malis-(a gift from B.J. Fowlkes), were purchased from Pharmingen (San
sen, B., and Luescher, I.F. (2000). Essential role of CD8 palmitoyla-Diego, CA). Biotinylated mAbs were revealed using streptavidin tri-
tion in CD8 coreceptor function. J. Immunol. 165, 2068–2076.color conjugate (Caltag, Burlingame, CA).
Backstrom, B.T., Muller, U., Hausmann, B., and Palmer, E. (1998).
Positive selection through a motif in the  T cell receptor. ScienceTissue Transplants
281, 835–838.Thymus and spleen tissue grafting under the kidney capsule was
performed according to standard methods. Donor and recipient Badiner, G., Goodman, T.G., and Lefrancois, L. (1993). Selection of
mice were between 6 and 8 weeks old at the time of transplant, and intestinal intraepithelial lymphocyte T cell receptors: evidence for a
mice were analyzed 6 weeks after the tissue grafting. dynamic tissue-specific process. Int. Immunol. 5, 223–226.
Bandeira, A., Itohara, S., Bonneville, M., Burlen-Defranoux, O., Mota-
Thymectomies Santos, T., Coutinho, A., and Tonegawa, S. (1991). Extrathymic origin
Six- to eight-week-old animals were thymectomized as previously of intestinal intraepithelial lymphocytes bearing T-cell antigen re-
described (Bandeira et al., 1991). Thymectomized animals recovered ceptor . Proc. Natl. Acad. Sci. USA 88, 43–47.
for 2 weeks before bone marrow transplants were performed. Upon
Barnden, M.J., Heath, W.R., and Carbone, F.R. (1997). Down-modu-
analysis of the thymectomized mice, the chest cavity was examined
lation of CD8 -chain in response to an altered peptide ligand en-
visually for the absence of any residual thymus tissue.
ables developing thymocytes to escape negative selection. Cell.
Immunol. 175, 111–119.
Production of Chimeras
Bendelac, A., Rivera, M.N., Park, S.H., and Roark, J.H. (1997). MouseBone marrow chimeras were produced according to standard meth-
CD1-specific NK1 T cells: development, specificity, and function.ods. In brief, bone marrow cells were purified from femur and tibia,
Annu. Rev. Immunol. 15, 535–562.and cell suspension was depleted of mature T cells using biotin-
Bruno, L., Fehling, H.J., and von Boehmer, H. (1996). The  T cellylated anti-CD90.2 antibodies and streptavidin-coated magnetic
receptor can replace the  receptor in the development of  lin-beads following the manufacturer’s instructions. The mature T cell
eage cells. Immunity 5, 343–352.population was 1% after depletion. Recipient mice received 1200
rad irradiation 1 day before injection with the T cell-depleted bone Capone, M., Troesch, M., Eberl, G., Hausmann, B., Palmer, E., and
marrow. A total of 5  106 to 1  107 cells were transferred by MacDonald, H.R. (2001). A critical role for the T cell receptor -chain
i.v. injection into the irradiated recipient mice. Chimeric mice were connecting peptide domain in positive selection of CD1-indepen-
analyzed 6 weeks after bone marrow transfer. dent NKT cells. Eur. J. Immunol. 31, 1867–1875.
Crooks, M.E., and Littman, D.R. (1994). Disruption of T lymphocyte
Antigen-Specific Cytotoxicity Assays positive and negative selection in mice lacking the CD8  chain.
TAP-deficient RMA-S cells were used as target cells. 106 target cells Immunity 1, 277–285.
were loaded with 250 M H-Y peptide (KCSRNRQYL) derived from Cruz, D., Sydora, B.C., Hetzel, K., Yakoub, G., Kronenberg, M., and
the Smcy protein or 25 g/ml OVA peptide (SIINFEKL) (both from Cheroutre, H. (1998). An opposite pattern of selection of a single
Macromolecular Resources, CO). Peptides were loaded in complete T cell antigen receptor in the thymus and among intraepithelial lym-
RPMI medium (GibcoBRL, Grand Island, NY), 10% FCS (HyClone, phocytes. J. Exp. Med. 188, 255–265.
Logan, Ut), and 1 M 2-ME (Fisher Scientific, Pittsburgh, PA) over-
Das, G., and Janeway, C.A., Jr. (1999). Development of CD8/ andnight at 25C and for 2 hr at 37C/5% CO2. Washed target cells were CD8/ T cells in major histocompatibility complex class I-deficientthen labeled with 100 Ci of 51Cr-sodium (ICN Biomedicals, Irvine,
mice. J. Exp. Med. 190, 881–884.CA) for 1 hr at 37C/5% CO2. Labeled target cells were washed 2,
DiGiusto, D.L., and Palmer, E. (1994). An analysis of sequence varia-counted, and resuspended at 1  105 cells/ml complete medium.
tion in the  chain framework and complementarity determiningTwo hundred microliter/well effector cells in complete medium were
regions of an allo-reactive T cell receptor. Mol. Immunol. 31,serially diluted in 1/2 steps in U-bottom 96-well plate (Costar, Cam-
693–699.bridge, MA) in triplicates. Fifty microliters of target cells/well was
added, including in wells without effector cells, for spontaneous Fink, P.J., Matis, L.A., McElligott, D.L., Bookman, M., and Hedrick,
S.M. (1986). Correlations between T-cell specificity and the structureand maximum release measurements. IEL from RAG	/	-recipient
mice were preincubated with 2.5  104 unloaded target cells for 1 of the antigen receptor. Nature 321, 219–226.
Immunity
364
Gao, G.F., and Jackobsen, B.K. (2000). Molecular interactions of ment in SCID mice that received co-isogenic CD4 T cells. Evidence
that mature post-thymic CD4 T cells can be induced to expresscoreceptor CD8 and MHC class I: the molecular basis for functional
coordination with the T-cell receptor. Immunol. Today 21, 630–636. CD8  in vivo. J. Immunol. 154, 2678–2686.
Ohteki, T., and MacDonald, H.R. (1993). Expression of the CD28Gapin, L., Cheroutre, H., and Kronenberg, M. (1999). Cutting edge:
costimulatory molecule on subsets of murine intestinal intraepithe-TCR  CD8 T cells are found in intestinal intraepithelial lym-
lial lymphocytes correlates with lineage and responsiveness. Eur.phocytes of mice that lack classical MHC class I molecules. J.
J. Immunol. 23, 1251–1255.Immunol. 163, 4100–4104.
Oida, T., Suzuki, K., Nanno, M., Kanamori, Y., Saito, H., Kubota, E.,Guehler, S.R., Bluestone, J.A., and Barrett, T.A. (1996). Immune devi-
Kato, S., Itoh, M., Kaminogawa, S., and Ishikawa, H. (2000). Roleation of 2C transgenic intraepithelial lymphocytes in antigen-bearing
of gut cryptopatches in early extrathymic maturation of intestinalhosts. J. Exp. Med. 184, 493–503.
intraepithelial T cells. J. Immunol. 164, 3616–3626.Guy-Grand, D., Cerf-Bensussan, N., Malissen, B., Malassis-Seris,
Park, S.H., Guy-Grand, D., Lemonnier, F.A., Wang, C.R., Bendelac,M., Briottet, C., and Vassalli, P. (1991a). Two gut intraepithelial CD8
A., and Jabri, B. (1999). Selection and expansion of CD8/ T celllymphocyte populations with different T cell receptors: a role for
receptor / intestinal intraepithelial lymphocytes in the absence ofthe gut epithelium in T cell differentiation. J. Exp. Med. 173, 471–481.
both classical major histocompatibility complex class I and nonclas-Guy-Grand, D., Malassis-Seris, M., Briottet, C., and Vassalli, P.
sical CD1 molecules. J. Exp. Med. 190, 885–890.(1991b). Cytotoxic differentiation of mouse gut thymodependent
Poussier, P., Edouard, P., Lee, C., Binnie, M., and Julius, M. (1992).and independent intraepithelial T lymphocytes is induced locally.
Thymus-independent development and negative selection of T cellsCorrelation between functional assays, presence of perforin and
expressing T cell receptor / in the intestinal epithelium: evidencegranzyme transcripts, and cytoplasmic granules. J. Exp. Med. 173,
for distinct circulation patterns of gut- and thymus-derived T lym-1549–1552.
phocytes. J. Exp. Med. 176, 187–199.Guy-Grand, D., Pardigon, N., Darche, S., Lantz, O., Kourilsky, P.,
Rocha, B., Vassalli, P., and Guy-Grand, D. (1991). The V beta reper-and Vassalli, P. (2001). Contribution of double-negative thymic pre-
toire of mouse gut homodimeric alpha CD8 intraepithelial T cellcursors to CD8 intraepithelial lymphocytes of the gut in mice
receptor /  lymphocytes reveals a major extrathymic pathwaybearing TCR transgenes. Eur. J. Immunol. 31, 2593–2602.
of T cell differentiation. J. Exp. Med. 173, 483–486.Hedrick, S.M., Matis, L.A., Hecht, T.T., Samelson, L.E., Longo, D.L.,
Rocha, B., Vassalli, P., and Guy-Grand, D. (1992). The extrathymicHeber-Katz, E., and Schwartz, R.H. (1982). The fine specificity of
T-cell development pathway. Immunol. Today 13, 449–454.antigen and Ia determinant recognition by T cell hybridoma clones
specific for pigeon cytochrome c. Cell 30, 141–152. Rocha, B., Vassalli, P., and Guy-Grand, D. (1994). Thymic and ex-
trathymic origins of gut intraepithelial lymphocyte populations inJordan, M.S., Boesteanu, A., Reed, A.J., Petrone, A.L., Holenbeck,
mice. J. Exp. Med. 180, 681–686.A.E., Lerman, M.A., Naji, A., and Caton, A.J. (2001). Thymic selection
Suzuki, K., Oida, T., Hamada, H., Hitotsumatsu, O., Watanabe, M.,of CD4CD25 regulatory T cells induced by an agonist self-peptide.
Hibi, T., Yamamoto, H., Kubota, E., Kaminogawa, S., and Ishikawa,Nat. Immunol. 2, 301–306.
H. (2000). Gut cryptopatches: direct evidence of extrathymic ana-Kappler, J.W., Staerz, U., White, J., and Marrack, P.C. (1988). Self-
tomical sites for intestinal T lymphopoiesis. Immunity 13, 691–702.tolerance eliminates T cells specific for Mls-modified products of
Sydora, B.C., Mixter, P.F., Holcombe, H.R., Eghtesady, P., Williams,the major histocompatibility complex. Nature 332, 35–40.
K., Amaral, M.C., Nel, A., and Kronenberg, M. (1993). Intestinal intra-Kaye, J., Vasquez, N.J., and Hedrick, S.M. (1992). Involvement of
epithelial lymphocytes are activated and cytolytic but do not prolifer-the same region of the T cell antigen receptor in thymic selection
ate as well as other T cells in response to mitogenic signals. J.and foreign peptide recognition. J. Immunol. 148, 3342–3353.
Immunol. 150, 2179–2191.
Kuo, S., El Guindy, A., Panwala, C.M., Hagan, P.M., and Camarini,
Sydora, B.C., Brossay, L., Hagenbaugh, A., Kronenberg, M., andV. (2001). Differential appearance of T cell subsets in the large and
Cheroutre, H. (1996). TAP-independent selection of CD8 intestinalsmall intestine of neonatal mice. Pediatr. Res. 49, 543–551.
intraepithelial lymphocytes. J. Immunol. 156, 4209–4216.
Kurts, C., Heath, W.R., Carbone, F.R., Allison, J., Miller, J.F., and
Yelon, D., and Berg, L.J. (1997). Structurally similar TCRs differ inKosaka, H. (1996). Constitutive class I-restricted exogenous presen-
their efficiency of positive selection. J. Immunol. 158, 5219–5228.tation of self antigens in vivo. J. Exp. Med. 184, 923–930.
Lefrancois, L., and Olson, S. (1994). A novel pathway of thymus-
directed T lymphocyte maturation. J. Immunol. 153, 987–995.
Leishman, A.J., Naidenko, O.V., Attinger, A., Koning, F., Lena, C.J.,
Xiong, Y., Chang, H.-C., Reinherz, E., Kronenberg, M., and Cherou-
tre, H. (2001). T cell responses modulated through interaction be-
tween CD8 and the nonclassical MHC class I molecule, TL. Sci-
ence 294, 1936–1939.
Levelt, C.N., de Jong, Y.P., Mizoguchi, E., O’Farrelly, C., Bhan, A.K.,
Tonegawa, S., Terhorst, C., and Simpson, S.J. (1999). High- and
low-affinity single-peptide/MHC ligands have distinct effects on the
development of mucosal CD8 and CD8 T lymphocytes. Proc.
Natl. Acad. Sci. USA 96, 5628–5633.
Lin, T., Matsuzaki, G., Kenai, H., Nakamura, T., and Nomoto, K.
(1993). Thymus influences the development of extrathymically de-
rived intestinal intraepithelial lymphocytes. Eur. J. Immunol. 23,
1968–1974.
MacDonald, H.R., Schneider, R., Lees, R.K., Howe, R.C., Acha-
Orbea, H., Festenstein, H., Zinkernagel, R.M., and Hengartner, H.
(1988). T-cell receptor V use predicts reactivity and tolerance to
Mlsa-encoded antigens. Nature 332, 40–45.
Matechak, E.O., Killeen, N., Hedrick, S.M., and Fowlkes, B.J. (1996).
MHC class II-specific T cells can develop in the CD8 lineage when
CD4 is absent. Immunity 4, 337–347.
Morrissey, P.J., Charrier, K., Horovitz, D.A., Fletcher, F.A., and Wat-
son, J.D. (1995). Analysis of the intra-epithelial lymphocyte compart-
